Contributor content
Presentation
Impact of worsening heart failure events and renal impairment on vericiguat drug use patterns in real-world care
Presentation
Risk of all-cause mortality and heart failure hospitalizations in patients treated with vericiguat in real world settings
Presentation
Age- and sex-specific characteristics and real-world use patterns of patients treated with vericiguat in Germany
Presentation
Sex and marital status modify the effect of remote patient management on mortality risk in patients hospitalized for acute systolic heart failure: Insights from the E-INH study
Presentation
LVEF-specific effects of remote patient management in patients with heart failure: a prespecified analysis of the TIM-HF2-trial
Presentation
Gender-specific efficacy of remote patient management (RPM) in patients with heart failure: a prespecified analysis of the TIM-HF2 trial
Presentation
What is the best time interval for health status assessments after discharge? Findings from the E-INH study
Presentation
MR-proADM is a strong independent predictor of long-term all-cause mortality risk in patients with chronic heart failure: results from the E-INH study
Presentation
